Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 108

Sort by

Sort Order Select

Journal Articles

Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity

Hoda Pourhassan, Corinna La Rosa, Flavia Chiuppesi, Alfredo Puing, Ibrahim Aldoss, Yoonsuh Park, Qiao Zhou, Veronica Karpinski, Katelyn Faircloth, Teodora Kaltcheva, Daisy Johnson, Sandra Ortega Francisco, John A. Zaia, Ryotaro Nakamura, Monzr M. Al Malki, Don J. Diamond, Sanjeet Singh Dadwal, Stephen J. Forman

Blood Adv (2022) 6 (6): 1645–1650.

https://doi.org/10.1182/bloodadvances.2021006282

Published: 2022

Includes: Supplemental data

Journal Articles

Eculizumab for refractory thrombosis in antiphospholipid syndrome

Habiba Hussain, Michael D. Tarantino, Shruti Chaturvedi, Keith R. McCrae, Jonathan C. Roberts

Blood Adv (2022) 6 (4): 1271–1277.

https://doi.org/10.1182/bloodadvances.2021005657

Published: 2022

Journal Articles

Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion–associated myeloid neoplasm

Blood Adv (2022) 6 (4): 1137–1142.

https://doi.org/10.1182/bloodadvances.2021004966

Published: 2022

Includes: Supplemental data

Journal Articles

Daratumumab for immune thrombotic thrombocytopenic purpura

Jana van den Berg, Johanna A. Kremer Hovinga, Claudia Pfleger, Inga Hegemann, Gregor Stehle, Andreas Holbro, Jan-Dirk Studt

Blood Adv (2022) 6 (3): 993–997.

https://doi.org/10.1182/bloodadvances.2021005124

Published: 2022

Journal Articles

Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience

Ava Diarra, Nicolas Duployez, Elise Fournier, Claude Preudhomme, Valérie Coiteux, Leonardo Magro, Bruno Quesnel, Maël Heiblig, Pierre Sujobert, Fiorenza Barraco, Marie Balsat, Quentin Scanvion, Eric Hachulla, David Launay, Ibrahim Yakoub-Agha, Louis Terriou,

Blood Adv (2022) 6 (3): 998–1003.

https://doi.org/10.1182/bloodadvances.2021004749

Published: 2022

Includes: Supplemental data

Journal Articles

Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis

Sebastian K. Eder, Raphaela Schwentner, Philipp Ben Soussia, Giulio Abagnale, Andishe Attarbaschi, Milen Minkov, Florian Halbritter, Caroline Hutter

Blood Adv (2022) 6 (3): 970–975.

https://doi.org/10.1182/bloodadvances.2021005442

Published: 2022

Includes: Supplemental data

Journal Articles

A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia

Chi-Keung Cheng, Hoi-Yun Chan, Yuk-Lin Yung, Thomas S. K. Wan, Alex W. K. Leung, Chi-Kong Li, Ke Tian, Natalie P. H. Chan, Joyce S. Cheung, Margaret H. L. Ng

Blood Adv (2022) 6 (2): 410–415.

https://doi.org/10.1182/bloodadvances.2021006064

Published: 2022

Includes: Supplemental data

Journal Articles

A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm

Peng Li, Shobi Venkatachalam, Daniela Ospina Cordona, Lorena Wilson, Tibor Kovacsovics, Karen A. Moser, Rodney R. Miles, David B. Beck, Tracy George, Srinivas K. Tantravahi

Blood Adv (2022) 6 (2): 405–409.

https://doi.org/10.1182/bloodadvances.2021005243

Published: 2022

Includes: Supplemental data

Journal Articles

Bilineal evolution of a U2AF1 -mutated clone associated with acquisition of distinct secondary mutations

Nathan D. Montgomery, Jonathan Galeotti, Steven M. Johnson, Leah Commander, Eric T. Weimer, Pranil K. Chandra, Tariq Nazir, Thomas B. Alexander, Joshua F. Zeidner, Matthew C. Foster

Blood Adv (2021) 5 (24): 5612–5616.

https://doi.org/10.1182/bloodadvances.2021005308

Published: 2021

Journal Articles

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1

Preeti Singh, Maninder Heer, Anastasia Resteu, Aneta Mikulasova, Mojgan Reza, Laëtitia Largeaud, Stéphanie Dufrechou, Naïs Prade, Rachel E. Dickinson, Jacinta Bustamante, Bénédicte Neven, Venetia Bigley, Eric Delabesse, Daniel Rico, Marlène Pasquet, Matthew Collin

Blood Adv (2021) 5 (24): 5631–5635.

https://doi.org/10.1182/bloodadvances.2021005217

Published: 2021

Includes: Supplemental data

Journal Articles

Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion

Mohammad S. Ebraheem, Madeleine Verhovsek

Blood Adv (2021) 5 (23): 5020–5022.

https://doi.org/10.1182/bloodadvances.2021004338

Published: 2021

Journal Articles

VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis

Vanessa E. Kennedy, Chelsea C. Wong, Jessica M. Hong, Theodore Peng, Sam Brondfield, Linda M. Reilly, Patricia Cornett, Andrew D. Leavitt

Blood Adv (2021) 5 (22): 4662–4665.

https://doi.org/10.1182/bloodadvances.2021005388

Published: 2021

Journal Articles

Anticoagulant therapy in patients with congenital FXI deficiency

Carlos Bravo-Pérez, María Jose Serna, Julio Esteban, Eugenia Fernandez-Mellid, Emilia Fontanes-Trabazo, Alvaro Lorenzo, Michael Calviño-Suárez, Antonia Miñano, José Padilla, Vanessa Roldán, Vicente Vicente, Javier Corral, María Eugenia de la Morena-Barrio

Blood Adv (2021) 5 (20): 4083–4086.

https://doi.org/10.1182/bloodadvances.2021005695

Published: 2021

Journal Articles

Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome

Andrew B. Song, Rahul Sakhuja, Nancy M. Gracin, Ronald Weinger, Raj S. Kasthuri, Hanny Al-Samkari

Blood Adv (2021) 5 (19): 3850–3854.

https://doi.org/10.1182/bloodadvances.2021004810

Published: 2021

Journal Articles

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Susanne Jung, Jochen Greiner, Stephanie von Harsdorf, Pavle Popovic, Roland Moll, Jens Schittenhelm, Kosmas Kandilaris, Volker Daniel, Alexander Kunz, Michael Schmitt, Peter Dreger

Blood Adv (2021) 5 (19): 3789–3793.

https://doi.org/10.1182/bloodadvances.2021004889

Published: 2021

Includes: Supplemental data

Journal Articles

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

Justin Anthony Chen, Yanli Hou, Krishna M. Roskin, Daniel A. Arber, Charles D. Bangs, Linda B. Baughn, Athena M. Cherry, Mark D. Ewalt, Andrew Z. Fire, Laure Fresard, Hutton M. Kearney, Stephen B. Montgomery, Robert S. Ohgami, Kathryn E. Pearce, Beth A. Pitel, Jason D. Merker, Jason Gotlib

Blood Adv (2021) 5 (17): 3492–3496.

https://doi.org/10.1182/bloodadvances.2020004174

Published: 2021

Includes: Supplemental data

Journal Articles

B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations

Kathryn A. Six, Ulrike Gerdemann, Anna L. Brown, Andrew E. Place, Alan B. Cantor, Matthew A. Kutny, Serine Avagyan

Blood Adv (2021) 5 (16): 3199–3202.

https://doi.org/10.1182/bloodadvances.2021004653

Published: 2021

Journal Articles

Effective anti-BCMA retreatment in multiple myeloma

Nicolas Gazeau, David Beauvais, Ibrahim Yakoub-Agha, Suman Mitra, Timothy B. Campbell, Thierry Facon, Salomon Manier

Blood Adv (2021) 5 (15): 3016–3020.

https://doi.org/10.1182/bloodadvances.2021004176

Published: 2021

Journal Articles

Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease

Kathryn E. Dane, John P. Lindsley, Thomas Kickler, Michael B. Streiff, Alison Moliterno, Jennifer Yui, Rakhi Naik, Shruti Chaturvedi

Blood Adv (2021) 5 (14): 2813–2816.

https://doi.org/10.1182/bloodadvances.2021004843

Published: 2021

Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz

Blood Adv (2021) 5 (13): 2794–2798.

https://doi.org/10.1182/bloodadvances.2021004957

Published: 2021

NARROW

Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity

Eculizumab for refractory thrombosis in antiphospholipid syndrome

Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion–associated myeloid neoplasm

Daratumumab for immune thrombotic thrombocytopenic purpura

Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience

Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis

A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia

A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm

Bilineal evolution of a U2AF1 -mutated clone associated with acquisition of distinct secondary mutations

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1

Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion

VITT following Ad26.COV2.S vaccination presenting without radiographically demonstrable thrombosis

Anticoagulant therapy in patients with congenital FXI deficiency

Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Lymphoid blast transformation in an MPN with BCR-JAK2 treated with ruxolitinib: putative mechanisms of resistance

B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations

Effective anti-BCMA retreatment in multiple myeloma

Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only